Some tend to live in neverland Todos is never g
Post# of 1418
(Total Views: 235)
Posted On: 07/28/2022 7:16:07 PM
Some tend to live in neverland
Todos is never going to have a product
Todos is never going to have revenue
Todos is never going have something that helps people suffering from covid
Todos is never going to do a Phase 2 trial
Todos is never going to release Phase 2 data
Todos is never going to close the JV
I'm sure it's now
Todos is never going to uplist
For those 'concerned' about the RS, exactly how to you uplist when the OTC share structure is usually way different than the major exchanges?
BTW, in the S-1 it says a range of 1:2 to 1:1,000
Why have 1:2?
Why limit 1:1000 as at a penny, that is $10. $10 gives you some cushion. But the neverlanders saying the stock is going lower forever. This isn't your IBIO.
Smart companies uplist when things are about to take off. When they are holding a royal flush. If the goal of a company is to uplist and figure the rest out later, 1000% of the time they will fail.
Can the sp get up to $2 so there is just a 1:2?
Anything is possible. Right now, Todos seems to be the only company with products that are helping people without major side effects. Let's see how this plays out.
Anyone figure out why Gerald went to Singapore yet?
Todos is never going to have a product
Todos is never going to have revenue
Todos is never going have something that helps people suffering from covid
Todos is never going to do a Phase 2 trial
Todos is never going to release Phase 2 data
Todos is never going to close the JV
I'm sure it's now
Todos is never going to uplist
For those 'concerned' about the RS, exactly how to you uplist when the OTC share structure is usually way different than the major exchanges?
BTW, in the S-1 it says a range of 1:2 to 1:1,000
Why have 1:2?
Why limit 1:1000 as at a penny, that is $10. $10 gives you some cushion. But the neverlanders saying the stock is going lower forever. This isn't your IBIO.
Smart companies uplist when things are about to take off. When they are holding a royal flush. If the goal of a company is to uplist and figure the rest out later, 1000% of the time they will fail.
Can the sp get up to $2 so there is just a 1:2?
Anything is possible. Right now, Todos seems to be the only company with products that are helping people without major side effects. Let's see how this plays out.
Anyone figure out why Gerald went to Singapore yet?
(2)
(0)